About: Mohamad Mohty

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Mohamad Mohty Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Mohty, Mohamad (19..-.... ; hématologue) Mohty, Mohamad (19..-.... ; hématologue) Mohty, Mohamad (19..-.... ; hématologue)
Life Event	http://www.idref.fr/076744094/birth
preferred label	Mohty, Mohamad (19..-.... ; hématologue)
name	Mohamad Mohty
dbpedia-owl:citizenship	http://sws.geonames.org/3017382/
Language	http://lexvo.org/id/iso639-3/fra
isni:identifierValid	0000000139162005
Given name	Mohamad
familyName	Mohty
note	Thèse d'université soutenue à Marseille le 3 novembre 2003. Directeur de thèse en 2006 Hématologue à l'AP-HP Hôpital Saint-Antoine (en 2020). Professeur d'hématologie à Sorbonne-Université, chercheur à INSERM.
gender	male
ORCID iD	0000-0002-7264-808X
Scopus ID	7004071645
is sameAs of	Mohty, Mohamad (19..-.... ; hématologue) Mohty, Mohamad (19..-.... ; hématologue) Mohty, Mohamad (19..-.... ; hématologue) Mohty, Mohamad (19..-.... ; hématologue)
is Thesis advisor of	http://www.sudoc.fr/174686099/id http://www.sudoc.fr/17468679X/id http://www.sudoc.fr/130782645/id http://www.sudoc.fr/158640152/id http://www.sudoc.fr/138942811/id Établissement d'un score prédictif de la réaction du greffon contre l'hôte (GVH) chronique extensive en allogreffe de cellules souches hématopoïétiques http://www.sudoc.fr/194059634/id http://www.sudoc.fr/110616588/id http://www.sudoc.fr/139459227/id Allogreffe avec conditionnement à intensité réduite dans les leucémies aiguës myéloïdes Cellules dendritiques et drogues immunomodulatrices http://www.sudoc.fr/182071200/id http://www.sudoc.fr/130785059/id http://www.sudoc.fr/182143899/id http://www.sudoc.fr/157118096/id Infection par l'herpesvirus humain de type 6 (HHV-6) après allogreffe de cellules souches hématopoïétiques, influence de la nature du greffon sur la réactivation virale Impact du plerixafor sur la mobilisation des cellules souches hématopoïétiques autologues chez les patients préalablement traités par fludarabine ou lénalidomide http://www.sudoc.fr/158639839/id http://www.sudoc.fr/164232281/id http://www.sudoc.fr/183219996/id Lymphomes B agressifs en rechute, réfractaires ou transformés et greffe de cellules souches hématopoïétiques http://www.sudoc.fr/254124445/id http://www.sudoc.fr/283872683/id
is Praeses of	http://www.sudoc.fr/283403578/id
is Author of	http://www.sudoc.fr/07674759X/id http://www.sudoc.fr/054144477/id Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate or High-Risk Acute Myeloid Leukemia in Complete Remission: a Study From the ALWP of the EBMT Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation Translational opportunities for targeting the Th17 axis in acute graft-vs.-host disease Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study Extending autologous transplantation as first line therapy in multiple myeloma patients with severe renal impairment: a retrospective study by the SFGM-TC Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies. Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC Impact of cyclosporine A concentration on acute graft‐vs‐host disease incidence after haploidentical hematopoietic cell transplantation TFH cells in systemic sclerosis Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC Involvement of the CX3CL1 (fractalkine)/ CX3CR1 pathway in the pathogenesis of acute graft-versus-host disease Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC. Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients Mechanisms of action of antithymocyte globulin: old dogs with new tricks! https://orbi.uliege.be/handle/2268/167459#id https://orbi.uliege.be/handle/2268/297861#id https://orbi.uliege.be/handle/2268/215718#id https://orbi.uliege.be/handle/2268/172673#id Prediction of Hematopoietic Stem Cell Transplantation Related Mortality-Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation Double umbilical cord blood transplantation for hematological malignancies: a long- term analysis from the SFGM-TC registry. Venetoclax does not impair activated T cell proliferation Final Primary Results from the Defifrance Registry Study: Effectiveness and Safety of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation https://serval.unil.ch/notice/serval:BIB_7F5FDC892B37#id https://orbi.uliege.be/handle/2268/243669#id https://orbi.uliege.be/handle/2268/308886#id https://orbi.uliege.be/handle/2268/227640#id Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT. Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia Letter to the editor Resolution of bortezomib-associated chalazia/blepharitis after switch to ixazomib: a case report https://archive-ouverte.unige.ch/unige:144215#id https://orbi.uliege.be/handle/2268/161918#id https://orbi.uliege.be/handle/2268/212265#id https://orbi.uliege.be/handle/2268/250600#id http://hub.abes.fr/edp/periodical/medsci/2003/volume_19/issue_5/medsci2003195p540/w Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood—a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation https://orbi.uliege.be/handle/2268/321950#id G-CSF mobilizes CD34 + regulatory monocytes that inhibit graft-versus-host disease Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease Measurable residual disease, FLT3‐ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1‐mutated acute myeloid leukemia Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software